AzTrials
AzTrials

Mandibular AsymmetryNCT04429113

Quad Helix and Correction of Mandibular Asymmetry

An observational study of Mandibular Asymmetry and Functional Shift of the Mandible, run by University Hospital, Montpellier at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To compare the effectiveness of the Quad Helix, an orthopaedic conventional appliance, in the correction of skeletal mandibular asymmetry, on frontal x-ray, in subjects treated before or after 7 years. Read more about this study

Who is it for?
Ages 4 to 13 years
What is being tested?
Maxillary expansion with conventional Quad Helix bonded on molars.
Type of treatment
Medical device
How many people
67 participants
Where
1 siteFrance
Study dates
1 Feb 2017to 30 Aug 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients of Orthodontic Department of the CHU of Montpellier

Who may be able to join

  • Unilateral Posterior Crossbite (at least one tooth) and skeletal mandibular asymmetry
  • Treated by Quad Helix in the Orthodontic Department of the CHU Montpellier
  • with frontal X-rays available at baseline and 12months later

Who cannot join

  • Incomplete File
  • Inadequate quality of x-rays

Trial locations and contacts

1 site in 1 country.

France1 site
  • Uhmontpellier

    Montpellier, 34295

Other trials in France

About this study

Official title: Is the Quad Helix More Efficient to Correct Mandibular Asymmetry Before Age 7? A Retrospective Comparative Study

To compare the effectiveness of the Quad Helix, an orthopaedic conventional appliance, in the correction of skeletal mandibular asymmetry, on frontal x-ray, in subjects treated before or after 7 years.

Read the detailed description

Introduction : Unilateral posterior crossbite (UPCB), often from dysfunctional and para-functional causes, leads to positional mandibular asymmetries that can develop at a very young age into skeletal mandibular deviation; hence the interest of early maxillary expansion. The purpose of this retrospective study was to compare the impact of maxillary expansion by Quad Helix (QH) on mandibular skeletal asymmetry correction before and after 7 years of age.

Materials and methods : All children with UPCB and skeletal mandibular asymmetry, who were treated by QH in the orthodontic department between February 2017 and August 2018 and who have done a radiography file at baseline (T0) and 12 months later (T1) have been included. The patients were divided into two groups according to age: under 7 years of age (early group G1) with QH adjusted on second primary molars and over up to 13 years old (late group G2) with QH adjusted on first permanent molars. The differences between the right and left sides of the mandible in corpus length L (main eligibility criterion) and ramus height H (secondary criterion) were compared between groups. X² test, Fisher's exact test and Wilcoxon rank-sum tests were used for baseline comparisons. A multifactorial analysis allowing adjustment on possible confounding factors was used with R software at a significance level of 5%.

Being tested
Maxillary expansion with conventional Quad Helix bonded on molars.
Keywords
Early treatment, Posterior unilateral cross bite, Quad helix

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Maxillary expansion with conventional Quad Helix bonded on molars.Device

    Maxillary expansion with conventional Quad Helix bonded on molars

Study groups in NCT04429113
Study groupRoleWhat they receive
G1 or Early GroupPatients treated before age 7 (Quad Helix on decidual second molars)
Receives: Device: Maxillary expansion with conventional Quad Helix bonded on molars.
G2 or Late GroupPatients treated between 7 and 13 years old (Quad Helix on first permanent molars)
Receives: Device: Maxillary expansion with conventional Quad Helix bonded on molars.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in the mandibular corpus length between the right and left side

    Difference in the mandibular corpus length between the right and left side : △L on conventional frontal x-ray.

    Measured: 1 day

Secondary outcomes (1)
  1. Difference in the mandibular ramus height between the right and left side of the mandibule

    Difference in the mandibular ramus height between the right and left side of the mandibule : △H on conventional frontal x-ray.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2020
  2. Study start1 Feb 2017
  3. Primary completion1 Aug 2019
  4. Study completion30 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
67 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04429113
Sponsor's protocol ID
RECHMPL20_0350
Status last verified
Jun 2020
First submitted
9 Jun 2020
Last updated
12 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Mandibular Asymmetry and Functional Shift of the Mandible, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in the mandibular corpus length between the right and left side (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in